PVX-410 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PVX-410 vaccine, covering 2025-10-01 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer [Phase 1]